Dr. Munro advises on device development, product research design, new business development, marketing programs, economic modeling, and legal and regulatory issues. Dr. Munro’s current or past corporate clients comprise a broad spectrum of pharmacology and device companies ranging from early-stage to multinational corporate entities many of which he has been, or is a member of, the Scientific Advisory Boards. He is currently the Principal at M.G. Munro Consulting, Chair of FIGO’s Menstrual Disorders Committee, and Voluntary Clinical Professor at the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA.

​

 

Dr. Munro’s clinical and research interests are oriented to the diagnosis, medical management, and minimally invasive approaches to gynecological disorders with particular interests in surgical education and training as well as the problem of abnormal uterine bleeding including investigation, medical and procedural interventions.

​

 

He has published more than 120 papers, 40 chapters, and three textbooks and is on the editorial boards of a number of well-known peer-reviewed journals. He recently launched the Women’s Health Research Collaborative (WHrC) designed to align stakeholders from the professional and lay communities with government, payers, employers, health care systems, and the life science industry to raise awareness of a spectrum of normalized women’s health conditions.